SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Diversa Corporation , a pioneer in developing high-performance specialty enzymes, announced today that it will be presenting at the Rodman & Renshaw 3rd Annual Global Healthcare Conference. The presentation is scheduled to be delivered at 4:50 a.m. (Eastern Time) on Monday, May 15, 2006 from Europe. Edward Shonsey, Chief Executive Officer of Diversa Corporation, is expected to provide a business overview and discuss the Company's recent accomplishments. The presentation will be webcast live and may be accessed for a limited period of time following the conference at http://wsw.com/webcast/rrshq8/dvsa.
About Diversa
Since 1994, San Diego-based Diversa Corporation has pioneered the development of high-performance specialty enzymes. The company possesses the world's broadest array of enzymes derived from bio-diverse environments as well as patented DirectEvolution(R) technologies. Diversa customizes enzymes for manufacturers within the alternative fuel, industrial, and health and nutrition markets to enable higher throughput, lower costs, and improved environmental outcomes. For more information, please visit www.diversa.com.
Contacts: Martin Sabarsky Corporate Development (858) 526-5166 msabarsky@diversa.com Julie Cunningham Townsend Inc. for Diversa (858) 457-4888 jcunningham@townsendinc.com
Diversa CorporationCONTACT: Martin Sabarsky, Corporate Development of Diversa Corporation,+1-858-526-5166, msabarsky@diversa.com; or Julie Cunningham of TownsendInc., +1-858-457-4888, jcunningham@townsendinc.com, for Diversa Corporation